The roles of insulin and of insulin-like growth factor signalling are of considerable therapeutic interest for aortic pathology given recent evidence suggesting that metformin, a known regulator of both signalling pathways65, could be an effective treatment for abdominal aortic aneurysm, and the consequent initiation of clinical trials testing this66,67. The gene discussed is INS; the disease is abdominal aortic aneurysm.